한국어
Quantus

Anbio Biotechnology Class A Ordinary Shares

NNNN · Nasdaq
$6.54-0.91%
2026-09-04 close

Anbio Biotechnology Class A Ordinary Shares last closed at $6.54 (-0.91%) on 2026-09-04. Listed on Nasdaq; price, financials and dividends update daily after market close.

Loading chart…
Close
No active signal.

New high + volume — the real recordrecord · not a prediction

Last 30 sessions
277 picks
Next-day win rate
44.2%
Avg next-day
-0.28%
vs market
-0.51%p

Every new-high-plus-volume pick we actually published (US market) — not this stock alone.

Trade plan

Fill entry, stop, account size and risk percent to get a share count. The stop must sit below the entry.

A calculator · not advice or a guarantee

Financials & valuation at a glance

Past reported results · not investment advice

More — deeper indicators

Financial safety

Reference indicatorAs of 2024
Safe zoneFinancial-metric reference signal
Altman Z'' zoneZ'' 19.93
Distress
Grey
Safe
The marker shows the current Z'' value within the displayed zones.
Altman Z''
19.93
Beneish M-Score
-1.53

Statistical manipulation-risk signal

Sloan accrual
1.55%

부실·조작 위험을 나타내는 사실 지표입니다. 투자 조언이 아니며, 검증 전이라 참고용입니다.

Factual information, not investment advice.

Earnings quality · Piotroski F-Score

5/9Moderate

Piotroski measures year-over-year financial improvement, not absolute quality.

Financial improvement score5/9

Profitability

  • Positive ROAPass
  • Positive OCFPass
  • Improving ΔROANot passed
  • Accruals (OCF > net income)Not passed

Leverage & liquidity

  • Lower debtNot passed
  • Higher current ratioNot passed
  • No new sharesPass

Efficiency

  • Higher gross marginPass
  • Higher asset turnoverPass

Calculation note: F7(신주)은 equity/asset 유지로 근사

Already-stable companies may score lower when year-over-year improvement is limited.

Factual information, not investment advice.

Risk sensitivity — adverse assumptions

Metric changes under stated assumptions; not a forecast or investment advice.

Base metrics

Operating margin
24.4%
Interest coverage
5.3x
Return on equity (ROE)
13.8%

Operating margin −5pp

Tolerable
Interest coverageBase 5.3x adverse case 4.2x
Return on equity (ROE)Base 13.8% adverse case 7%

Revenue −15%

Tolerable
Interest coverageBase 5.3x adverse case 4.5x
Return on equity (ROE)Base 13.8% adverse case 7.7%

Interest rate +2pp

Tolerable
Interest coverageBase 5.3x adverse case 4.8x
Return on equity (ROE)Base 13.8% adverse case 9.2%

Interest coverage limit

Current margin 19.8pp

Interest coverage limit at an operating margin of 4.6%

Interest expense coverage threshold

Connections

AI-extracted related companies · for reference

🔗 See in the full market map →

Recent filings

Filings for overseas stocks are on the way. For now we cover Korean stocks only.

About Anbio Biotechnology Class A Ordinary Shares
What technical signals does Anbio Biotechnology Class A Ordinary Shares (NNNN) have?
Anbio Biotechnology Class A Ordinary Shares current technical signals: no active technical signal.
Is Anbio Biotechnology Class A Ordinary Shares a cup-and-handle pattern?
No. Anbio Biotechnology Class A Ordinary Shares has no valid cup-and-handle signal right now.
What are Anbio Biotechnology Class A Ordinary Shares's financials and valuation?
Anbio Biotechnology Class A Ordinary Shares's income statement, balance sheet and cash flow are free for the most recent 8 years; the full history is on Pro. PER/PBR, dividend yield and sector valuation bands are free.

Like these rules? Backtest them.

Run this signal on this ticker in the free backtest builder — same window, no install.

Backtest this rule ↗

Quantus Signal · live data · not investment advice · Privacy Policy